Cell Design Labs
Producing cancer-fighting cell therapies, UCSF startup, Cell Design Labs Inc. was acquired by Gilead for $567M.
Zebrafish Aid Drug Discovery
Zebrafish-to-patient approach at UCSF speeds search for childhood epilepsy treatments.
Okada's Lab Targets Novel 'Neoantigen'
Hideho Okada's lab leads the way for new immunotherapy for deadly childhood brain cancer.
Vanda License Agreement
$46M deal using CFTR activators to treat dry eye, constipation, kidney disease & more.
Pionyr to Target Cancer Cells
$62M deal to focus on antibody treatments to boost immune cells to fight cancer

As part of our public mission, UC San Francisco strives to translate our scientific discoveries for public use and benefit. Whether it’s a new drug molecule, diagnostic, medical device or digital health application, our goal is to ensure the best new therapies and technologies can make their way to the patient as efficiently and safely as possible.

Innovation Ventures comprises multiple groups specializing in business development, intellectual property, licensing and entrepreneurship including: 

  • Catalyst Program accelerates translation of UCSF research into products with clinical impact through customized Industrial product development mentorship, and funding.
  • Center for Digital Health Innovation collaborates with innovators from UCSF and beyond to envision, realize and evaluate game-changing digital health technologies. 
  • Entrepreneurship Center provides the knowledge, support and connections needed by scientists and clinicians who want to create a startup venture to commercialize their technology.
  • Strategic Alliances connects industry with UCSF researchers, building collaborations and longer-term partnerships that are mutually beneficial. 
  • Technology Management negotiates license agreements that allow commercial partners to develop products based on UCSF inventions.